SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maul Coin

Maul Coin is generating buzz as an early-stage community-driven project with an active developer, attracting attention from investors looking to move beyond typical pump-and-dump cycles. The community is actively pushing for mainstream platform visibility and increased trading volume to support their long-term goal of hitting significant market cap milestones.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is gaining momentum and trending as investors react to a strategic payroll infrastructure partnership with Stellar, fueling optimism for broader institutional adoption. The community is actively discussing the potential for future XRP collaboration and a possible Coinbase listing, with many using the current price consolidation as a strategic accumulation phase.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is trending as investors highlight its ultra-low circulating supply and small market capitalization as key drivers for significant growth potential. The community is actively discussing the token's upside, with many calling for increased volume and exchange listings to catalyze a major breakout.

Veil Cash is a privacy application leveraging zk-SNARKs on Base L2, enabling verified depositors to achieve privacy and anonymity within a pool of trusted users.  Veil Cash is a non-custodial privacy protocol on Base L2. Veil Cash's goal will be enabling verified users to achieve privacy and anonymity from trusted pools.  Veil is a set of smart contracts that will allow users that are deemed as verified users to deposit into the protocol. Users can later withdraw their deposits from another address without creating a link between these two addresses.   Verified users are those who meet certain criteria based on both on-chain and off-chain data.

Veil-project

VEIL is trending as community members rally behind its privacy-focused technology on the Base network, often citing support from Coinbase Ventures as a key catalyst. Enthusiasts are actively discussing the project's long-term potential for adoption and its mining and staking features, viewing it as a essential tool for digital sovereignty.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing heightened investor interest driven by a combination of its ongoing strategic pivot into pharmaceutical manufacturing, a fortified balance sheet, and market speculation regarding potential domestic supply chain contracts. Community discussion remains heavily focused on the company's turnaround progress, its status as a potential beneficiary of new pharmaceutical import tariffs, and bullish long-term value projections based on its infrastructure and asset base.

Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.

Grace Therapeutics Inc.

Grace Therapeutics is gaining momentum as investors anticipate the upcoming PDUFA date for its drug candidate GTx-104. The community is focused on the potential for institutional accumulation and the stock's low float, with many discussing the strategic value of the asset as the company nears its regulatory catalyst.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

The XRP community is currently polarized, caught between frustration over stagnant price action and excitement regarding Ripple's recent treasury platform integration with SWIFT. While some investors are bracing for further volatility and potential token supply unlocks, others are doubling down on long-term conviction, pointing to pending regulatory developments as the potential catalyst for institutional adoption.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is experiencing heightened volatility and community debate as investors weigh the company's aggressive expansion and strong sales against concerns regarding its high valuation and inflationary pressures. Market participants are intensely focused on upcoming earnings, with active discussions split between bullish expectations for the brand's long-term growth and bearish caution over current price multiples.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is attracting significant attention as investors track its Phase 2 LOTUS trial progress and potential for its lead asset, AVTX-009, to impact the competitive immunology market. The community is actively discussing recent analyst coverage, including buy ratings and optimistic price targets, while maintaining a cautious dialogue regarding the company's long-term financing needs and historical volatility.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing heightened social media activity and trading volume driven by investor interest in its post-quantum cryptography features and recent institutional developments, including a shift toward US-based operations. The community remains deeply divided, with long-term holders expressing conviction in the project's technology and future adoption, while active traders continue to debate its recent price volatility and past performance relative to broader market trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Indian equity markets closed higher on Wednesday, led by gains in the financials, auto, and healthcare indices.The markets are expected to open slightly positive on Thursday, tracking global market cues. Most Asian markets were in the green today after the United States struck a trade deal with Japan, while reports of a similar deal with the European Union also&nbsp;whetted investor appetite.&nbsp;&nbsp;The Gift Nifty, an early indicator of the Nifty 50, edged 0.01% higher at 25,294.5.Here are the stocks to watch out for ahead of today’s session.Results Today&nbsp;&nbsp;Bajaj Finance, Nestle India, SBI Life Insurance Company, Canara Bank, ACC, Aditya Birla Sun Life AMC, Adani Energy Solutions, APL Apollo Tubes, CG Power and Industrial Solutions, Coromandel International, Cyient, Hexaware Technologies, Indian Energy Exchange, Indian Bank, Motilal Oswal Financial Services, Mphasis, REC, Tanla Platforms, Trident, Ujjivan Small Finance Bank, and UTI Asset Management CompanyEarnings ImpactInfosys:&nbsp;Reported an 8.7% rise in profit to ₹6,921 crore, 7.5% revenue growth to ₹42,279 crore, and raised its constant currency revenue guidance to 1 - 3%. The firm maintained its operating margin guidance at 20 – 22%.Dr. Reddy’s Laboratories:&nbsp;Posted a 1.9% increase in profit to ₹1,417.8 crore and an 11.4% rise in revenue, though North America sales declined 11%.Tata Consumer Products:&nbsp;Saw its profit rise 15% to ₹334.2 crore and revenue grow 9.8% to ₹4,778.9 crore.Bajaj Housing Finance:&nbsp;Profit jumped 20.7% to ₹583 crore, NII was up 33.4%, while gross and net NPAs inched up to 0.3% and 0.13%, respectively.CMS Info Systems:&nbsp;Reported a 3% increase in profit to ₹93.6 crore and 4.7% revenue growth to ₹627.4 crore.Persistent Systems:&nbsp;Delivered a 38.7% surge in profit to ₹424.9 crore and a 21.8% rise in revenue to ₹3,333.6 crore.Cigniti Technologies:&nbsp;Saw profit skyrocket 527.6% to ₹65.9 crore on 14% revenue growth and no exceptional loss this quarter.Oracle Financial Services Software:&nbsp;Posted a 4.1% rise in profit to ₹641.9 crore and 6.4% growth in revenue to ₹1,852.2 crore.Filatex India:&nbsp;Saw profit climb 26% higher to ₹40.7 crore despite a 0.5% dip in revenue, aided by a spike in other income.Force Motors:&nbsp;Reported a 52.4% surge in profit to ₹176.4 crore and a 21.9% increase in revenue to ₹2,297.3 crore.Supreme Petrochem:&nbsp;Witnessed a 33.6% decline in profit to ₹80.9 crore and an 11.9% fall in revenue to ₹1,386.5 crore.Bikaji Foods International:&nbsp;Posted a 2.8% profit growth to ₹59.9 crore and a 14.2% rise in revenue to ₹652.7 crore.Stocks to watchTilaknagar Industries: Signed an agreement to acquire the Imperial Blue business from Pernod Ricard India for ₹4,150 crore via a slump sale.Natco Pharma: Will acquire a 35.75% stake in Adcock Ingram, South Africa, for ₹2,000 crore and invest up to ₹2,100 crore to set up a wholly-owned subsidiary in the country.Religare Enterprises:&nbsp;The Reserve Bank of India has lifted all restrictions on Religare Finvest Ltd,&nbsp;a subsidiary, ending over seven years of regulatory curbs.Reliance Industries: Unit Nauyaan Tradings increased its stake in Nauyaan Shipyard to 93.9% after acquiring an additional 9.9% from Welspun Corp for ₹54.7 crore.Angel One: Secured approval to invest up to ₹104 crore for a 26% stake in a life insurance joint venture with LivWell Holding.IndusInd Bank: Approved fund-raising of up to ₹30,000 crore via debt and equity and received RBI nod for its promoters to nominate up to two board directors.Monarch Networth Capital: Received in-principle approval from SEBI to establish a proposed mutual fund.Inox Wind: To raise ₹1,249.33 crore through a rights issue of 10.41 crore shares at ₹120 each, with the record date set as July 29.BEML: Received an order worth ₹293.82 crore from the Ministry of Defence for the supply of HMV 6x6 vehicles.India Pesticides: Plans to set up a ₹65 crore herbicide intermediate project at its Sandila plant by September 2026 and appointed Udaya Bhaskar Mantripragada as Whole-Time Director after Rajendra Singh Sharma’s resignation.Delhivery: Completed the acquisition of the remaining 21.12% stake in Ecom Express.Fortis Healthcare:&nbsp;Signed an operation and maintenance (O&amp;M) agreement with Gleneagles Healthcare India.Satin Creditcare: Approved the incorporation of a new subsidiary named Satin Growth Alternatives.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Trading Radar For July 24: Infosys, Dr. Reddy’s, Natco Pharma, BEML On Investors’ Watchlist

Bajaj Finance, Nestle India, SBI Life Insurance Company, Canara Bank, and ACC, among others, are set to report their quarterly earnings later today

Equity

Bajaj Finance, Nestle India, SBI Life Insurance Company, Canara Bank, and ACC, among others, are set to report their quarterly earnings later today


India Pesticides Limited manufactures agro-chemical products. It diversified into manufacturing herbicide and fungicide technical and active pharmaceutical ingredients. Its businesses include Manufacturing Facilities, Research & Development, Product Offering, and Market. The company was founded in 1984 and is headquartered in Lucknow, India.

IPL.NSE
India Pesticides Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest IPL.NSE News

IPL.NSEIndia Pesticides Ltd.